The ARC Training Centre in Biopharmaceutical Innovation aims to transform Australia’s growing biopharmaceutical industry, an advanced manufacturing capability contributing to Australia’s economic growth. The CBI combines the research and development, and manufacturing expertise and capabilities of the industry partners and The University of Queensland (UQ). Industry-driven research projects ensures industry-ready graduates drive growth in the sector. The CBI housed within the Australian institute for Bioengineering and Nanotechnology (AIBN) at UQ and collaborates with the National Biologics Facility, also housed within the AIBN. The Centre combines the research and development, and manufacturing expertise and capabilities of the industry partners and the University of Queensland. Industry-driven research projects ensures industry-ready graduates drive growth in the sector. The training and research outcomes of the CBI will lead to new biopharmaceuticals and antibody-based reagents, enhanced production methods, improved manufacturing capabilities and a cohort of specialist scientists, which will benefit the economy and positively impact health-care.